May 16 - 18, 2024 Brasilia - Brazil

Main Auditorium

8 am – 8:10 am

Official opening

8:10 am – 8:50 am

General session 1



8:10 am – 8:20 am

Effect of vitamin D supplementation on the pathological complete response to neoadjuvant chemotherapy in women with breast cancer: a randomized clinical trial

Eduardo Carvalho Pessoa (BRA)

8:20 am – 8:30 am

Breast cancer screening based on physical examination of the breast performed by community health workers: Itaberaí Project

Priscila Dias Watanabe (BRA)

8:30 am – 8:40 am

Machine learning model to predict resistance to neoadjuvant chemotherapy in breast cancer

Martina Lichtenfels (BRA)

8:40 am – 8:50 am


8:55 am – 9:25 am

Gold Satellite Symposium – MSD – How immunotherapy redefines the treatment of high-risk triple negative breast cancer

9:30 am – 9:50 am

Silver Satellite Symposium – DAIICHI SANKYO – The journey of the patient with breast cancer – care with a multidisciplinary team



Rosemar Macedo Sousa Rahal (BRA)

9:50 am – 10:30 am

Coffee Break

10:30 am – 11:10 am

General session 2



10:30 am – 10:40 am

Randomized clinical trial: breast cancer screening based on physical examination performed by community health workers

Danielle Cristina Netto Rodrigues (BRA)

10:40 am – 10:50 am

Vacuum-Assisted Excision (VAE): a single-step approach to the diagnosis and treatment of Early Breast Cancers (EBC) – initial report

Henrique Lima Couto (BRA)

10:50 am – 11 am

External prostheses after mastectomy: adhesion, manufacture and selection of a low-cost functional model to be performed in developing countries

René Aloisio da Costa Vieira (BRA)

11 am – 11:10 am


11:15 am – 11:35 am

Silver Satellite Symposium – LILLY – Cyclin inhibitors: do the differences make a difference in clinical practice?

11:40 pm – 11:45 am

BBCS 2024 Awards 


11:45 pm – 12:05 pm

Mini Conference: How should molecular classification be approached in a dynamic scenario of changes in gene expression during the course of the disease?



2 pm – 2:40 pm

General session 3



2 pm – 2:10 pm

Is it possible to omit axillary surgery after neoadjuvant therapy for breast cancer? Preliminary outcomes in patients who underwent neoadjuvant treatment in the ongoing VENUS trial – a randomized controlled clinical trial

Maria Beatriz de Paula Leite Kraft (BRA)

2:10 pm – 2:20 pm

Disparity in access to anti-her-2 therapies in neoadjuvant chemotherapy: a prognostic analysis based on real world data between public and private systems in Brazil

Marcelo Antonini (BRA)

2:20 pm – 2:30 pm

The diffusion sequence by magnetic resonance in the diagnosis of breast cancer: an analysis of accuracy

Ilse Franco de Oliveira (BRA)

2:30 pm – 2:40 pm


2:45 pm – 3:25 pm

Gold Satellite Symposium – NOVARTIS – A2A: Treatment of HR+/HER2- luminal breast cancer


3:30 pm – 4:10 pm

Table: There are no fools here. The clinical study presented by its author | co-author



10’ Prospective study: Impact of breast magnetic resonance imaging on oncoplastic surgery and on indications of mastectomy in patients who were previously candidates to breast conserving surgery


10’ Outcomes after elevation of serratus anterior fascia flap versus serratus muscle flap in direct-to-implant breast reconstruction following mastectomy: a prospective study


10’ Factors associated with unsatisfactory cosmetic results in oncoplastic surgery



4:10 pm – 4:40

Coffee Break 

4:40 pm – 5:10 pm

Gold Satellite Symposium – ZEISS – The case for intraoperative radiotherapy: results and insights from the TARGIT a trial



5:15 pm – 5:45 pm

ASTRAZENECA – Mechanisms of endocrine resistance


5:50 pm – 6:30 pm

General session 4



5:50 pm – 6 pm

First interim analysis of radiotherapy data after 4.5 years of sentinel lymph node biopsy Versus no axillary surgery in early breast cancer clinically and UltraSonographically node negative: a prospective randomized controlled trial – VENUS Trial

Danielle Cristina Miyamoto Araújo (BRA)

6 pm – 6:10 pm

Patient-reported aesthetic outcomes in Oncoplastic Breast Surgery compared to Conventional Breast-Conserving Surgery: a systematic review and meta-analysis

Charles Karel Martins Santos (BRA)

6:10 pm – 6:20 pm

Breast conservation therapy or mastectomy and breast reconstruction in the treatment of locally advanced and/or Multifocal/Multicentric breast cancer? Systematic review and meta-analysis

Aline Regina Nunes Reis (BRA)

6:20 pm – 6:30 pm